bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies will go public soon, but the exact IPO date is still unknown.
Stock Price: $6.75
Confirmed IPO price
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2020 | 2021 |
|---|---|---|
| Selling, General & Admin
|
0.99 | 0.88 |
| Research & Development
|
1.61 | 1.33 |
| Operating Expenses
|
2.6 | 2.21 |
| Operating Income
|
-2.6 | -2.21 |
| Interest Expense / Income
|
0.38 | 1 |
| Other Expense / Income
|
4.28 | 3.12 |
| Pretax Income
|
-7.27 | -6.32 |
| Income Tax
|
0 | 0 |
| Net Income
|
-7.27 | -6.33 |
| Net Income Common
|
-7.27 | -6.33 |
| Effective Tax Rate
|
-0.04% | -0.03% |
| EBITDA
|
-6.86 | -5.32 |
| Depreciation & Amortization
|
0.02 | 0 |
| EBIT
|
-6.88 | -5.32 |
Source: IPO financials are sourced from
S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).